Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA
NCT ID: NCT02969889
Last Updated: 2017-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2016-06-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study
NCT05927519
Comparison of Endotracheal Intubation Over the Aintree With Fiberoptic Bronchoskop Via the I-gel and LMA Protector
NCT03501602
Orotracheal Intubation in Adult Patients: A Comparison of Standard Airtraq , Nasotracheal Airtraq Combined With a Stylet Inserted Endotracheal Tube and Standard Airtraq Combined Fiberoptic Intubation
NCT03709524
Airway Management in Morbidly Obese Patients: A Comparison of Intubating Laryngeal Mask Fastrack and Air Q as a Conduit for Fiberoptic Intubation
NCT04453683
Tracheal Intubation With Collar Immobilisation : a Comparison of Glidescope and Fastrach
NCT02245880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Divided into two groups ; Airtraq and ILMA .
BMI\>35, upper airway tumour , respiratory infection less than ten days, excluded from this study.
patients demographic and airway variables were recoded. Patients were premedicated. After standard anesthesia induction, anesthesia was induced with propofol and fentanyl. Rocuronium was used for neuromuscular blockade.
The device insertion and intubation times, number of intubation attempts, mucosal damage, need for optimization maneuvers, effects on hemodynamic parameters and postoperative minor complications were recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intubation time
handling the device till the endotracheal tube passing through the glottis
Airtraq
video laryngoscope with a channel
ILMA
insertion time
handling of the device till the glottic visualization
Airtraq
video laryngoscope with a channel
ILMA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Airtraq
video laryngoscope with a channel
ILMA
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI\>35
Exclusion Criteria
* patients undergoing head and neck surgery
* upper respiratory infection less than 10 days prior the surgery
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zehra Ipek ARSLAN
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zehra Arslan
Role: PRINCIPAL_INVESTIGATOR
Kocaeli University Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kocaeli University School of Medicine
Kocaeli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KOU KAEK 2014/137
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.